ON
ONCOMARK LIMITED
Grant-FundedCORDISOncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer
Digital Health · Biotech · SaaS
ONCOMARK LIMITED is a private SME recorded in CORDIS in Ireland, with participation in 10 EU research and innovation projects. Its recorded projects include “OncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€7,779,015
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇮🇪Ireland
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
ONCOMARK LIMITED is a private SME recorded in CORDIS in Ireland, with participation in 10 EU research and innovation projects. Its recorded projects include “OncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
Digital HealthBiotechSaaS
Tags:Digital HealthBiotechSaaS
Company Info
ONCOMARK LIMITED Info
Funding
EU Grants€7,779,015